UB
IRWD icon

UMB Bank’s Ironwood Pharmaceuticals IRWD Stock Holding History

UMB Bank’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-722
Closed -$3.2K – 2135
2024
Q4 		$3.2K Sell
722
-378
-34% -$1.53K ﹤0.01% 1839
2024
Q3 		$4.53K Buy
1,100
+930
+547% +$5K ﹤0.01% 1762
2024
Q2 		$1.11K Buy
170
+107
+170% +$757 ﹤0.01% 1950
2024
Q1 		$549 Buy
+63
New +$764 ﹤0.01% 1954

Other funds holding IRWD

SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return

UMB Bank's IRWD Position: Q1 2025 in Review

UMB Bank sold out of Ironwood Pharmaceuticals (IRWD) in Q1 2025, closing a stake of 722 shares — an estimated $3.2K sold.

UMB Bank first reported a position in IRWD in Q1 2024 and held it in 4 quarters. The position peaked at $4.53K in Q3 2024. 200 funds tracked by Wall St. Rank hold IRWD as of Q1 2025.

  • UMB Bank reported no remaining Ironwood Pharmaceuticals position as of Q1 2025 after selling out during the quarter.
  • UMB Bank sold 722 Ironwood Pharmaceuticals shares in Q1 2025, an estimated $3.2K.
  • UMB Bank first reported a position in Ironwood Pharmaceuticals in Q1 2024 and held it in 4 quarters.
  • UMB Bank's Ironwood Pharmaceuticals position peaked at $4.53K in Q3 2024.
  • 200 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q1 2025.

Based on UMB Bank's 13F filing for Q1 2025, filed 14 Apr 2025.